| Chronic Lymphocytic Leukemia |
1 |
1 |
| Salary and Compensation |
0 |
0.6 |
| Acute Myeloblastic Leukemia |
0 |
0.55 |
| Leukemia |
0 |
0.53 |
| Revenue and Practice Management |
0 |
0.39 |
| Europe |
0 |
0.33 |
| Acute Leukemia |
0 |
0.28 |
| Hematology |
0 |
0.27 |
| Chronic Myelogenous Leukemia |
0 |
0.21 |
| Cancer |
0 |
0.2 |
| Blood |
0 |
0.13 |
| Board Certification |
0 |
0.13 |
| Disability |
0 |
0.13 |
| Hospital |
0 |
0.13 |
| Jobs |
0 |
0.13 |
| Biologic Therapy |
0 |
0.11 |
| Tyrosine Kinase Inhibitor |
0 |
0.09 |
| Body Mass Index |
0 |
0.07 |
| Epidemiology |
0 |
0.07 |
| Flow Cytometry |
0 |
0.07 |
| Immunology |
0 |
0.07 |
| Insurance |
0 |
0.07 |
| Medical Life |
0 |
0.07 |
| Prognosis |
0 |
0.07 |
| Tyrosine Kinase |
0 |
0.07 |
| Obesity |
0 |
0.03 |